Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

GlaxoSmithKline (GSK) has initiated a succession plan for a new chairman following the announcement by its current chairman, Philip Hampton, of his intention to step down as non-executive Chairman. Philip was appointed to the company’s Board of...

GlaxoSmithKline (GSK) has completed its $5.1-billion acquisition of Tesaro, an oncology-focused company based in Waltham, Massachusetts. The deal was announced in December 2018. Tesaro is a commercial-stage biopharmaceutical company, with a...

Genentech, a member of the Roche Group, has appointed Alexander Hardy, currently Head of Global Product Strategy, as chief executive officer (CEO), effective March 1, 2019. He succeeds Bill Anderson, who was recently appointed CEO, Roche...

Allergan has announced it will establish a research and development (R&D) site in Cambridge, Massachusetts.The site will be led by Don Frail, PhD, Senior Vice President of Research and External Scientific Innovation (RESI) and Non-Clinical and...

AstraZeneca has announced a reorganization of its research and development (R&D) and commercial units and has changed some of its executive management for those areas. Under the new structure, AstraZeneca will form two R&D units: one...

Torrent Pharmaceuticals, an India-based pharmaceutical company, is expanding its voluntary recall from two lots of losartan potassium tablets USP to a total of 10 lots to the consumer level due to the detection of trace amounts of an...

Eli Lilly and Company has agreed to acquire Loxo Oncology, a Stamford, Connecticut-based biopharmaceutical company, for $235.00 per share in cash, or approximately $8.0 billion. Loxo Oncology is focused on the development and commercialization of...

Teva Pharmaceutical Industries reports that it has resolved its ongoing dispute with Amgen over Teva’s generic cinacalcet HCl product. Teva and Amgen have been involved in patent-infringement litigation, and Teva recently received approval for, and...